Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 18/20 | 0.37 |
| ▸ | DRD3 | P35462 | 8/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8897546 | 1.00 | ESR1 (0.38) | ESR1ESR2DRD2DRD3HTR1A | |
| SCHEMBL8895514 | 0.82 | DRD2 (0.37) | ESR1ESR2DRD2DRD3 | |
| SCHEMBL8895505 | 0.82 | DRD2 (0.37) | ESR1ESR2DRD2DRD3 | |
| SCHEMBL8558153 | 0.79 | ESR1 (0.35) | ESR1ESR2 | |
| SCHEMBL8558150 | 0.78 | ESR1 (0.35) | ESR1ESR2 | |
| SCHEMBL8896472 | 0.77 | ESR1 (0.35) | ESR1ESR2 | |
| SCHEMBL8897713 | 0.74 | MEN1 (0.35) | ESR1ESR2 | |
| SCHEMBL8897664 | 0.73 | KMT2A (0.37) | ESR1ESR2 | |
| SCHEMBL7423187 | 0.70 | ESR1 (0.39) | ESR1ESR2 | |
| SCHEMBL8565611 | 0.70 | DCUN1D1 (0.39) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5612335-A | ANTICOAGULANTS; COMBATING/PREVENTING DISEASES WHERE CELL AGGREGATES OCCUR OR CELL-MATRIX INTERACTIONS PLAY A PART | KARL THOMAE GMBH (DE) | 1997-03-18 | — | — | US | disclosed |
| US-5519036-A | IMIDAZOLIDINONES, ANTICOAGULANTS, CELL AGGREGATION PREVENTION | KARL THOMAE GMBH (DE) | 1996-05-21 | — | — | US | disclosed |